InsidersTradesSigma
에이프로젠 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 에이프로젠 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Industrials sector, 에이프로젠 has published 149 reports. Market capitalisation: €49.3bn. The latest transaction was filed on 16 July 2026 (Purchase). Among the most active insiders: 지베이스. Every trade is free.
147
Insider Decl.
n/a
Thresholds
€1m
22 ops.
Buy Volume
€3m
68 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,581 of 28,065 companies
9.0
score / 100
Value1
Quality17
FCF yld-115%
Earn yld-125%
EV/EBITDA·
ROE-33%
Gross mgn28%
Net mgn-60%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 16 July 2026
Declarations149 total
Other
Other(filed)
Other
Other(filed)
25 of 149 declarations
About 에이프로젠
Aprogen is a company operating in the industrial sector, listed on the XKRX. It focuses on the development and production of biopharmaceutical products.